Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of ...

An experimental antibiotic called EVG7 has shown promise against gram-positive bacterium Clostridioides difficile. | Drug ...

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile—commonly known ...

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile - commonly known as C. diff - are a serious and persistent problem for patients and ...

Crestone, Inc. ("Crestone") today announced recent publication in the leading infectious disease journal, The Lancet Infectious Diseases, of positive results from a Phase 2 clinical trial evaluating ...

In today's Morning Rounds newsletter: the high-stakes search for a new CDC director, the impact of immigration policy on ...

Crestone, Inc. (“Crestone”) today announced recent publication in the leading infectious disease journal, The Lancet Infectious Diseases, of positive results from a Phase 2 clinical trial evaluating ...

Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 International Clinical Trials Acurx is launching a ground-breaking clinical trial ...

STATEN ISLAND, N.Y., March 9, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of ...

Success with agents starts with embedding them in workflows, not letting them run amok. Context, skills, models, and tools ...

The 2026 Ford Ranger Super Duty dual cab chassis is heavier, wider and more robust than a regular Ranger. It’s also packed ...